Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES

Area of Science:

• Structural biology and virology
• Immunology and chemokine research

Background:

• Certain chemokines inhibit human immunodeficiency virus (HIV) by blocking coreceptors CCR5 and CXCR4 on host cells.
• Understanding chemokine structure-function relationships is vital for designing novel antiviral therapeutics.

Purpose of the Study:

• To identify structural determinants of CC chemokine RANTES' CCR5 recognition and HIV-inhibitory activity.
• To explore the role of RANTES dimerization in its biological functions.
• To design and evaluate a RANTES-based peptide mimetic for therapeutic potential.

Main Methods:

• Structural analysis to identify critical residues for CCR5 binding.
• Investigation of dimerization's impact on chemokine function.
• Design and synthesis of a retroinverted RANTES peptide mimetic.

Main Results:

• Specific residues forming a solvent-exposed hydrophobic patch on RANTES are critical for CCR5 recognition.
• RANTES' biological activity is dependent on dimerization, exposing a large hydrophobic surface.
• The designed retroinverted RANTES peptide mimetic retained both HIV-antagonistic and chemotaxis-antagonistic functions.

Conclusions:

• Structural insights into RANTES-CCR5 interactions guide the development of HIV entry inhibitors.
• Dimerization is a key feature for RANTES' antiviral and chemotactic activities.
• Retroviral RANTES mimetics represent a promising strategy for novel therapeutic agents against HIV.